Balaxi Pharmaceuticals Limited

NSEI:BALAXI 株式レポート

時価総額:₹5.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Balaxi Pharmaceuticals バランスシートの健全性

財務の健全性 基準チェック /56

Balaxi Pharmaceuticalsの総株主資本は₹2.0B 、総負債は₹176.6Mで、負債比率は8.8%となります。総資産と総負債はそれぞれ₹2.6Bと₹569.8Mです。 Balaxi Pharmaceuticalsの EBIT は₹446.3Mで、利息カバレッジ比率26.6です。現金および短期投資は₹622.9Mです。

主要情報

9.6%

負債資本比率

₹194.04m

負債

インタレスト・カバレッジ・レシオ26x
現金₹625.72m
エクイティ₹2.01b
負債合計₹569.79m
総資産₹2.58b

財務の健全性に関する最新情報

Recent updates

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

財務状況分析

短期負債: BALAXIの 短期資産 ( ₹2.1B ) が 短期負債 ( ₹542.0M ) を超えています。

長期負債: BALAXIの短期資産 ( ₹2.1B ) が 長期負債 ( ₹27.8M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: BALAXI総負債よりも多くの現金を保有しています。

負債の削減: BALAXIの負債対資本比率は、過去 5 年間で0%から8.8%に増加しました。

債務返済能力: BALAXIの負債は 営業キャッシュフロー によって 十分にカバー されています ( 27.6% )。

インタレストカバレッジ: BALAXIの負債に対する 利息支払いEBIT ( 26.6 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘